Padeliporfin

Status:: Do Not Prescribe (DNP)
Decision Date:: December 2018

Comments

DO NOT PRESCRIBE (DNP): NICE TA546 for untreated localised prostate cancer.

Black Drug Classifications

6: Have NICE guidance that recommends they should not be used